HB 923 amends the State Lottery Law to redirect lottery revenue toward providing pharmaceutical assistance for elderly residents. It directly affects seniors who qualify for prescription drug aid under state programs by modifying eligibility determination procedures. The key provision updates how income and asset thresholds are calculated to determine who qualifies for this assistance. The bill became law on November 24, 2025, after approval by both legislative chambers and the governor.
SB 88 amends Pennsylvania's Insurance Company Law to require health insurance plans sold in the state to cover specific breast imaging services without cost-sharing for policyholders. It mandates annual mammograms for women 40+ and physician-recommended mammograms for women under 40, plus MRI and other breast imaging for those at average or higher risk of breast cancer due to factors like family history, genetic mutations, or dense breast tissue. The law specifies coverage for screening, supplemental, and diagnostic exams but does not require coverage for mastectomies or override standard deductibles/copays beyond the minimum required services. This replaces prior requirements that allowed cost-sharing and excluded MRI coverage.
SB 731 amends the existing Pharmaceutical Assistance Contract for the Elderly (PACE) program to add a new "Needs Enhancement Tier" for determining eligibility. This tier would allow more elderly residents to qualify for prescription drug assistance based on specific financial or health needs. The bill changes how eligibility is assessed under the program, making it easier for seniors with higher needs to access medication support. The bill recently passed final passage on November 12, 2025, and is now referred to Rules & Executive Nominations.
HB 749 updates Pennsylvania's public welfare laws to streamline assistance programs and improve service access. It requires copayments for subsidized child care, changes reporting for SNAP benefits, and mandates reports on transitioning to chip-enabled access cards for benefits. The bill removes regulatory barriers for outpatient behavioral health services provided within clinic facilities, allowing services to be billed as part of the clinic visit. It also requires additional reports to the General Assembly regarding medical assistance eligibility and nonemergency medical transportation services.
HB 446 requires hospitals and ambulatory surgical facilities in Pennsylvania to offer patients unused, facility-provided medication at no additional cost upon discharge, if the prescriber determines it's clinically appropriate for continuing treatment. The bill specifies that this applies only to non-controlled, multi-dose medications like eye drops, creams, or inhalers (excluding IV drugs or controlled substances), and mandates clear discharge instructions with usage details and contact information. Providers acting in good faith are protected from liability for patient misuse, and such medication offers are exempt from standard outpatient dispensing rules. This directly affects patients discharged from hospitals or ambulatory facilities and the healthcare facilities providing their care.
HB 1974 creates a new Contingency Management Support Grant Program within the Department of Drug and Alcohol Programs. The bill establishes a mechanism for distributing grants to support substance use disorder treatment programs that use evidence-based contingency management approaches (like providing rewards for treatment adherence). This program directly affects licensed treatment providers and individuals receiving substance use disorder services by providing funding for these specific support services. The bill amends the 1929 Administrative Code to authorize this grant program under the department's existing authority.
HB 1212 requires Pennsylvania maternal health programs to provide drug screening and awareness education to patients. It also mandates the inclusion of fatherhood engagement strategies in prenatal care discussions, directly affecting pregnant individuals and their partners receiving maternal health services. The bill imposes specific duties on the Joint State Government Commission to develop and oversee these program requirements. These provisions aim to integrate substance use prevention and family involvement into standard maternal health care protocols.
HB 564 updates Pennsylvania law to establish a new mental health crisis response system. It requires the Department of Human Services to create and operate this system, including training crisis responders and coordinating care. The bill directly affects individuals experiencing mental health crises and the state agencies responsible for emergency mental health services. Key provisions mandate specific duties for DHS to ensure timely, accessible crisis support statewide. The bill passed final passage on July 14, 2025, and is now under review by the Health & Human Services committee.
SB 475 creates a framework for Pennsylvania courts to establish specialized "problem-solving" treatment courts (including veterans, drug, mental health, and DUI courts) and modifies probation rules. It allows courts to create "veterans tracks" within existing treatment programs and requires judges to consider a defendant's employment status when sentencing for technical probation violations. The bill specifically permits up to 30 days of incarceration to allow defendants to enter treatment courts instead of imposing full sentences for technical probation violations. This directly affects Pennsylvania courts, probation officers, and individuals on probation who commit minor violations.
HB 1527 updates the existing Rare Disease Advisory Council established in 2017, clarifying its structure and responsibilities. The bill directly affects patients with rare diseases and requires coordination among the Department of Health, Insurance Department, Department of Human Services, and Department of Education. Key provisions mandate the council to advise state agencies on rare disease research, treatment access, insurance coverage, and resource allocation. It also specifies how departments must collaborate on policies impacting rare disease patients, ensuring a unified state approach.
